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Introduction
Previous studies found a presence of atrial septal defect
(ASD) in some cases of patients with migraine and
respective efficacy of ASD closure as a treatment of
migraine.
Purpose
To study an influence of atrial septal defect (ASD) closure
on clinical course of migraine in children.
Methods
Interviewing was conducted in 75 pediatric patients (age
10 to 18 years) operated for ASD (surgical or occluder
implantation) in Children’s National Cardiology Center
«RNPC Cardiology» (n = 75, male 31, female 44, mean
age = 15.2 ± 3.4 years) to identify their migraine attacks,
migraine specific clinical pictures (evaluation of inten-
sity, location of pain, aura), differentiate migraine pain
from other types of headache.
Results
Before ASD closure migraine was presented in 8 patients
(10.67%): 2 males (25%), 6 females (75%). Ñomplete disap-
pearance of migraine after operation was remarked in 2
patients (25%). Reduction of migraine symptoms was
found in other 6 patients (75%). Reduction/disappearance
of migraine within 1-7 days after ASD closure was
observed in 7 patients (87.5%) and within 7 to 14 days in 1
patient (12.5%). Noteworthy, in 6 patients (6.67%)
migraine debut was observed in the early postoperative
period (after ASD closure). In all 5 patients migraine starts
early in postoperative period (1 to 3 days). Migraine was
transient in all 5 patients (100%) persisting for 7-14 days
to 3.5 years.
Conclusions
The study indicate that closure of ASD in children
effectively reduced migraine in most patients (77.8%),
and completely eliminated migraine attacks in other
22.2% of cases, most often in early postoperative period
(88.9%). Most often migraine decreased / disappeared in
the period 1-14 days after ASD closure. Probability of
migraine reduction /disappearance > 14 days after ASD
closure is minimal. In some patients (6.8%) debut of
migraine was observed early (within first 3 days) in post-
operative period but migraine symptom were transient
in all patients (100%).
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